Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen
about
Hepatitis C virus and vaccine developmentConstruction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c miceInhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c miceThe evaluation of hepatitis C virus core antigen in immunized BALB/c mice.Immunization with Brugia malayi Myosin as Heterologous DNA Prime Protein Boost Induces Protective Immunity against B. malayi Infection in Mastomys coucha.Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c miceComparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNAOxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization.The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model.HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells.Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model.Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant.Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence.
P2860
Q27001610-D72B21F0-0F2D-4640-B477-826E52F48A68Q33909134-471F08B5-0097-4572-AE58-921754C35623Q33962697-AA14568F-B894-4FF8-B229-A0CD68FF0329Q34425267-51C4870D-A805-4781-8614-930B14EDBDB2Q35023899-FD831058-2A2A-4FB5-A52C-B767417BCBC4Q36142757-3996C794-2785-4A07-985B-DC08A01C2EF6Q36187270-D0082CAB-CDAB-4D9D-AB26-85C1E3182602Q36246596-28AE6654-B788-4964-9871-0B0E38FEB6C1Q36280098-04F32400-3809-4FB8-99FB-E804F6B60124Q37530475-F4177A7E-0F48-4C1F-B9FB-6EBF32D9507BQ38820096-7C3F8B4B-41FB-4FBE-B153-78DB05CAE858Q38868301-1365C2D7-84AF-418E-B27A-E042E7B25E55Q39574503-49250EC2-634D-48A3-BD63-8346104C5C1AQ42208607-1D319B65-5336-42B2-8AAB-5D10161F7470Q51009640-4868421E-3167-423D-8C9C-7A9474A504BA
P2860
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancement of the expression ...... ein boost immunization regimen
@en
Enhancement of the expression ...... in boost immunization regimen.
@nl
type
label
Enhancement of the expression ...... ein boost immunization regimen
@en
Enhancement of the expression ...... in boost immunization regimen.
@nl
prefLabel
Enhancement of the expression ...... ein boost immunization regimen
@en
Enhancement of the expression ...... in boost immunization regimen.
@nl
P2093
P2860
P356
P1476
Enhancement of the expression ...... ein boost immunization regimen
@en
P2093
Dace Skrastina
Ekaterina Alekseeva
Elizaveta Starodubova
Eriks Kushners
Irina Egorova
Irina Sominskaya
Maria Isaguliants
Marija Mihailova
Natalia Petrakova
Paul Pumpens
P2860
P2888
P356
10.1186/1479-0556-7-7
P577
2009-06-08T00:00:00Z
P5875
P6179
1011296812